The FDA is warning consumers about a nitrosamine compound called NDMA, or N-Nitrosodimethylamine, also known as dimethylnitrosamine (DMN), which is an ingredient in a heartburn drug called Zantac. The company that makes this drug, which is sold through prescription and also over-the-counter, has recalled all Zantac OTC in the United States. The first statement by the FDA about this issue was issued on September 13, 2019. At the time, they were investigating impurities in blood pressure and heart failure medicines, and recommended numerous recalls of those types of products. The FDA asked companies that produce ranitidine medications, including Zantac, to conduct testing on their products. There are inconsistencies in preliminary set results of this ingredient in Zantac products, … [Read more...]